8-K: 3M Reports Strong Q1 Results, Initiates 2024 Guidance Post-Solventum Spin-off

3M exceeded expectations in the first quarter of 2024, achieving organic growth and double-digit adjusted earnings growth, while also completing the spin-off of Solventum and finalizing key legal settlements.

Summary

• 3M reported first-quarter 2024 results with sales of $8.0 billion, a slight decrease of 0.3% year-over-year, but adjusted sales reached $7.7 billion with organic growth of approximately 1%.
• GAAP earnings per share were $1.67, down 5% year-over-year, while adjusted earnings per share were $2.39, showing a double-digit increase year-over-year.
• The company successfully completed the spin-off of Solventum on April 1st, and finalized legal settlements for Public Water Suppliers and Combat Arms Earplugs.
• 3M has initiated full-year 2024 guidance reflecting Solventum as a discontinued operation and updated its capital allocation framework.
• William 'Bill' Brown has been named CEO, effective May 1st, with Mike Roman transitioning to Executive Chairman.
• The company returned $835 million to shareholders via dividends in the first quarter.
• 3M's full-year 2024 adjusted earnings per share is forecasted to be between $6.80 and $7.30.

Sentiment

Score: 7

Explanation: The sentiment is positive due to better-than-expected results, the completion of the Solventum spin-off, and the finalization of major legal settlements. However, the slight decrease in total sales and the significant financial commitments related to legal settlements temper the overall positive outlook.

Positives

• 3M demonstrated strong operational performance, leading to better-than-expected results.
• The company achieved a return to organic sales growth.
• Adjusted earnings per share showed a significant increase of 21% year-over-year.
• The successful completion of the Solventum spin-off marks a strategic milestone.
• Finalizing major legal settlements reduces uncertainty and potential future liabilities.
• The company is returning capital to shareholders through dividends.

Negatives

• Total sales decreased slightly by 0.3% year-over-year.
• GAAP earnings per share decreased by 5% year-over-year.
• The company faces significant financial commitments related to legal settlements, including up to $10.3 billion for public water suppliers and $6.0 billion for Combat Arms Earplugs.

Risks

• The company faces risks related to worldwide economic conditions, political instability, and regulatory changes.
• Fluctuations in foreign currency exchange rates could impact financial results.
• Liabilities and outcomes of contingencies related to PFAS chemicals pose a significant risk.
• The company is exposed to risks related to legal proceedings, including those described in their reports.
• There are risks associated with the spin-off of the Health Care business, including potential business disruption and the diversion of management time.
• The company faces risks related to the Combat Arms Earplugs settlement.

Future Outlook

3M initiated full-year 2024 guidance, with adjusted earnings per share expected to be between $6.80 and $7.30, reflecting Solventum as a discontinued operation. The company expects a dividend payout ratio of approximately 40% of adjusted free cash flow.

Management Comments

• We delivered results that were better than our expectations as we returned to organic growth and achieved double digit adjusted earnings growth.
• We improved performance in our businesses through strong operational execution, completed the spin-off of Solventum, and finalized two major legal settlements, said 3M chairman and CEO Mike Roman.
• The progress we have made in executing our strategic priorities, positions the company for long-term shareholder value creation as Bill Brown assumes the role of 3M CEO.

Industry Context

The spin-off of Solventum reflects a broader trend of companies streamlining their portfolios to focus on core businesses. The legal settlements are significant for the industry, as they address long-standing liabilities related to PFAS and other issues. The company's focus on operational improvements and strategic priorities aligns with industry best practices for long-term value creation.

Comparison to Industry Standards

• 3M's adjusted operating margin of 21.9% is a strong result compared to industrial peers such as Honeywell (which reported an adjusted operating margin of 20.9% in Q1 2024) and General Electric (which reported an adjusted operating margin of 15.4% in Q1 2024).
• The organic sales growth of approximately 1% is modest compared to some peers, but is a positive sign given the challenges faced by the company.
• The legal settlements, while costly, are similar to other large industrial companies that have faced significant litigation related to environmental and product liability issues, such as DuPont and Bayer.
• The spin-off of Solventum is a strategic move similar to other large conglomerates that have divested non-core businesses to improve focus and shareholder value, such as Johnson & Johnson's spin-off of Kenvue.

Management Changes

Legal Proceedings

• 3M finalized a settlement with U.S. public water suppliers for up to $10.3 billion, payable over 13 years.
• A settlement for Combat Arms Earplugs litigation was also finalized, with 3M paying up to $6.0 billion between 2023 and 2029.

Stakeholder Impact

• Shareholders will benefit from the dividend payout and the potential for long-term value creation.
• Employees may experience changes due to the spin-off and restructuring activities.
• Customers may see changes in product offerings and services due to the strategic shifts.
• Suppliers may be impacted by changes in 3M's supply chain and procurement strategies.
• Creditors will be impacted by the company's debt levels and settlement obligations.

Next Steps

• 3M will continue to execute its strategic priorities.
• The company will focus on operational improvements.
• 3M will monetize its 19.9% stake in Solventum within five years.
• The second-quarter dividend is expected to be declared in May 2024, subject to board approval.

Key Dates

Keywords

3M, Solventum, spin-off, earnings, legal settlements, PFAS, organic growth, dividends, financial results, guidance